Meet John Fevurly
Strategic guidance for global pharmaceutical industry titans.
As the director of commercial strategy at Cambridge Bio Development, John Fevurly offers extensive consulting proficiency for premiere medical producers. His tenure is marked by steering through intricate international terrains and shifting market forces, utilizing a superior framework forged from profound bio-sector immersion.
An expert in enterprise scaling and high-level negotiation, he offers the confidential direction necessary to assess and finalize prestigious licensing deals. His efforts guarantee the peak value of each asset is realized through meticulous strategic mapping and top-tier project leadership that transcends basic tactical support.
Past administrative focus, John is noted for his sharp grasp of complex corporate dynamics. He serves as a reliable ally for leaders seeking brilliance, integrity, and a history of achieving successful results in major pharmaceutical integrations. Contact 480-888-6564 or john@cambridgebiodev.com for more information.
Pivotal choices demand an informed sector collaboration partner.
John's Experience
Founder & President, Pharma Market Access Consulting
Founder and President, Pharma Market Access Consulting. Executive advisor to specialty, small, and large pharma on regulatory strategy, market access, discounting, pricing, and PBM contracting and analysis.
Executive Director, Senior Advisor – US Market Access
Advisor to CEOs and Market Access leaders on pre‑launch regulatory strategy, specialty reimbursement, pricing, discounting, and formulary strategy for US and international pharmaceutical manufacturers.
Senior Director, Market Access
Advised CEOs and Market Access leaders on product launch strategy, specialty reimbursement, medical and pharmacy pricing, discount and contract negotiations, and senior‑level access across major US payers and health systems.
National Director, Enterprise Sales & Market Access
Led national and regional market access strategy and PBM/health plan contracting, overseeing $9B+ in business and directing B2B relationships across major US payers and health systems.
President’s Club & Hall of Fame Honors
6× President’s Club winner and 2× Hall of Fame inductee, recognized for driving profitable formulary access, value‑based contracts, and long‑term payer partnerships.
Sr. National Brand Director – SINGULAIR
Led the launch of SINGULAIR for asthma and allergic rhinitis, exceeding a $100M first‑year sales forecast and growing the brand from $0 to $1.4B in under four years, recognized as one of the most successful respiratory launches in history.